What is the vision of the Biometrics BU in 2022?

With the backing of exciting new investors, ClinChoice is charting a new course that combines our expertise and ambition to aid the continuous development and monitoring of new drugs, devices, and vaccines. Listen to Mahesh Mudnur – President, Asia-Pacific, and Sridhar Punniamurthi – Director, Statistical Programming, as they share their vision for the Biometrics group in 2022.